Elan reaches agreement in patent dispute

Elan and Mayo Foundation for Medical Education and Research jointly announced today that they have entered into an agreement related to each party's Alzheimer's disease research efforts.

The agreement resolves a patent dispute and facilitates used by both parties of an array of research tools in combating the disease.

The resolution of this dispute provides Mayo and Elan with cross-licenses necessary to pursue their

respective ongoing Alzheimer's research and development efforts.

Mayo is a not-for-profit organization with a mission to meet patients’ needs through integrated clinical practice, education and research.